Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Classification and Prediction System of MAFLD Based on Liver Biopsy

NCT06795646 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT06795646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Classification and Prediction System of MAFLD Based on Liver Biopsy
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
February 8, 2025
Completion date
December 31, 2038
Enrollment
2,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction associated steatotic liver disease, metabolic dysfunction-associated steatohepatitis (mash)